These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4625046)

  • 1. Report on national surveys of cytologic facilities.
    Manos NE; Robins M
    CA Cancer J Clin; 1972; 22(4):221-5. PubMed ID: 4625046
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on national surveys of cytologic facilities.
    Willis RJ; Watanabe G
    CA Cancer J Clin; 1968; 18(4):219-23. PubMed ID: 4992872
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations from the CDC. An assessment of Pap smears and hysterectomies among women in the United States.
    Saraiya M; Lee NC; Blackman D; Smith MJ; Morrow B; McKenna MT
    J Womens Health Gend Based Med; 2002 Mar; 11(2):103-9. PubMed ID: 11975858
    [No Abstract]   [Full Text] [Related]  

  • 4. StatBite: Percentage of women who had a pap smear in the last 3 years, 2005.
    J Natl Cancer Inst; 2008 Jun; 100(12):841. PubMed ID: 18544736
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of cytologic criteria of bacterial vaginosis: examination of 2,841 Papanicolaou-stained vaginal smears.
    Demirezen S
    Diagn Cytopathol; 2003 Sep; 29(3):156-9. PubMed ID: 12951684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast examinations with Pap smears.
    Shipp RH
    Am Fam Physician; 1976 Oct; 14(4):119-20. PubMed ID: 983917
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytologic screening and rescreening in detection and prevention of preclinical cervical cancer.
    Lindberg LG; Ahlgren M; Nordqvist SR
    Gynecol Oncol; 1977 Jun; 5(2):121-33. PubMed ID: 881124
    [No Abstract]   [Full Text] [Related]  

  • 8. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).
    Sawaya GF; Grady D; Kerlikowske K; Valleur JL; Barnabei VM; Bass K; Snyder TE; Pickar JH; Agarwal SK; Mandelblatt J
    Ann Intern Med; 2000 Dec; 133(12):942-50. PubMed ID: 11119395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRANSLATION TEAM APPROACH: PSYCHOMETRICS OF A VIETNAMESE PAP TESTING SURVEY.
    Nguyen-Truong CK
    Commun Nurs Res; 2011; 44():73-80. PubMed ID: 27254888
    [No Abstract]   [Full Text] [Related]  

  • 10. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop.
    Am J Surg Pathol; 1992 Sep; 16(9):914-6. PubMed ID: 1415910
    [No Abstract]   [Full Text] [Related]  

  • 11. The Bethesda System for cervical/vaginal cytologic diagnoses: a note of caution.
    Herbst AL
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):449-50. PubMed ID: 2381622
    [No Abstract]   [Full Text] [Related]  

  • 12. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.
    Anal Quant Cytol Histol; 1989 Oct; 11(5):291-7. PubMed ID: 2803441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proposals after analysis of some Swedish surveys. Health control every 5 years for adults when adequate resources for primary care become available].
    Nord Med; 1977 May; 92(5):138-41. PubMed ID: 866100
    [No Abstract]   [Full Text] [Related]  

  • 14. Formal proposal to combine the Papanicolaou Numerical System with Bethesda terminology for reporting cervical/vaginal cytologic diagnoses.
    Frankel K
    Diagn Cytopathol; 1994; 10(4):395-6. PubMed ID: 7924818
    [No Abstract]   [Full Text] [Related]  

  • 15. The Bethesda system for cervical/vaginal cytologic diagnoses.
    Herbst AL
    Clin Obstet Gynecol; 1992 Mar; 35(1):22-7. PubMed ID: 1544245
    [No Abstract]   [Full Text] [Related]  

  • 16. The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.
    J Reprod Med; 1989 Oct; 34(10):779-85. PubMed ID: 2677354
    [No Abstract]   [Full Text] [Related]  

  • 17. Rates of abnormalities and infectious agents in cervical smears from female inmates in Texas: comparison with private and university clinic patients.
    Logrono R; Wong JY
    Tex Med; 1999 Sep; 95(9):60-3. PubMed ID: 10518440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical Pap smear usage in Arkansas, resurvey, 1976.
    Steinkamp RC; Meade JH; Hunter WC; Riggs C
    J Ark Med Soc; 1978 Jun; 75(1):55-7. PubMed ID: 149103
    [No Abstract]   [Full Text] [Related]  

  • 19. Consumer control of carcinoma of the cervix.
    Lewis CE
    Am J Obstet Gynecol; 1974 Jul; 119(5):669-74. PubMed ID: 4834392
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of suboptimal cytologic smears. Persistent inflammatory smears.
    McLachlan N; Patwardhan JR; Ayer B; Pacey NF
    Acta Cytol; 1994; 38(4):531-6. PubMed ID: 8042417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.